Selenomethionine

CHEMBL113178 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

196.1 g/mol

LogP

—

Phase

4

Selenomethionine is an organic selenium compound, the primary dietary form of selenium in plants and a precursor to selenocysteine-containing selenoproteins with antioxidant functions. It is used as a selenium supplement and has been investigated for chemopreventive properties in age-related macular degeneration, asthma, and various cancers. As a methionine analog, it is incorporated into proteins in place of methionine and serves as a selenium reservoir in the body.

Molekularmasse

196,1200 g/mol

TPSA

63,30 Å²

Therapeutische Bereiche

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Age-Related Macular Degeneration Non-Small Cell Lung Cancer Asthma Chronic Obstructive Pulmonary Disease Non-Alcoholic Fatty Liver Disease Lymphoma Breast Cancer HIV/AIDS Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

C[Se]CC[C@H](N)C(=O)O

InChI

InChI=1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1

Molecular Formula

C5H11NO2Se

HBD / HBA

2 / 3

Rotierbare Bindungen

4

Schwere Atome

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Selenomethionine is an organic selenium compound, the primary dietary form of selenium in plants and a precursor to selenocysteine-containing selenoproteins with antioxidant functions. It is used as a selenium supplement and has been investigated for chemopreventive properties in age-related macular degeneration, asthma, and various cancers. As a methionine analog, it is incorporated into proteins in place of methionine and serves as a selenium reservoir in the body.

Yes, Selenomethionine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL113178. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 15103. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Selenomethionine auf PillFYI

Struktur

Schnelldaten

Formel: C5H11NO2Se
Synonyme: 4

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.